HomeTrialNCT07221578
🔬NCT07221578Phase 3RECRUITING

Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder

Study Summary

This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a single oral dose of VQW-765 compared to placebo in adults with social anxiety disorder.

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment500 participants
Primary Completion
Lead SponsorVanda Pharmaceuticals
Data Retrieved2026-04-11 04:31:05.188572+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.